Markets · 1 sources covering this

How Eli Lilly’s CEO Plans to Defeat Pharma’s Boom-Bust Cycle

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then starting his first term, was excoriating them for their high prices. A mounting number of reports showed that soaring costs were even forcing some diabetics to ration insulin. Ricks, the 11th CEO in Lilly’s 150-year history, concedes that one was a pub…

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
How Eli Lilly’s CEO Plans to Defeat Pharma’s Boom-Bust Cycle
When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then starting his first term, was excoriating them for their high prices. A mounting number of reports showed that soaring costs were even forcing some diabetics to ration insulin. Ricks, the 11th CEO in Lilly’s 150-year history, concedes that one was a pub…
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/b9f93bafe9955e1f435ab7510674b7687168ff6e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="How Eli Lilly’s CEO Plans to Defeat Pharma’s Boom-Bust Cycle"></iframe>

How Eli Lilly’s CEO Plans to Defeat Pharma’s Boom-Bust Cycle

How 1 sources are covering this